The government said Tuesday that Novo Nordisk's (NVO) drugs - Ozempic and Rybelsus for Type 2 diabetes - will cost $274 for a month's supply in 2027 for people covered by Medicare. Wegovy, which is ...
Novo Nordisk is also currently awaiting a decision from the FDA, having previously applied for approval of its Wegovy weight-loss pill. As part of the U.S. pricing deal with the administration earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback